Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Celularity, Inc. (CELU) had Stock-Based Compensation of $15.86M for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
$17.98M |
|
$14.19M |
|
$19.66M |
|
$-1.69M |
|
$43.58M |
|
$-25.60M |
|
$39.80M |
|
$14.21M |
|
$14.21M |
|
$14.19M |
|
$14.19M |
|
$14.19M |
|
$14.19M |
|
$-25.60M |
|
$-12.55M |
|
13.99M |
|
14.98M |
|
$1.00 |
|
$0.90 |
|
| Balance Sheet Financials | |
$33.50M |
|
$75.66M |
|
$367.56M |
|
$401.07M |
|
$62.09M |
|
-- |
|
$140.08M |
|
$202.16M |
|
$198.90M |
|
$-41.79M |
|
$198.90M |
|
14.89M |
|
| Cash Flow Statement Financials | |
$-137.88M |
|
$-5.24M |
|
$119.84M |
|
$52.08M |
|
$28.80M |
|
$-23.27M |
|
|
Stock-Based Compensation |
$15.86M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.54 |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
-9.40% |
|
-142.42% |
|
-142.42% |
|
-69.84% |
|
79.03% |
|
78.95% |
|
$-143.11M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
3.70 |
|
2.58 |
|
141.45 |
|
7.14% |
|
-33.96% |
|
3.54% |
|
7.14% |
|
$13.36 |
|
$-9.55 |
|
$-9.20 |
|